Home THIS WEBSITE IS INTENDED FOR HEALTHCARE PROFESSIONALS (HCPs) ONLY

Sylvant logo Menu


DosingRecommended dosing of SYLVANT®:1

  • 11 mg/kg given over 1 hour as an intravenous infusion
  • Administer every 3 weeks until treatment failure

Use aseptic technique for reconstitution and preparation of dosing solution.1

Once reconstitutes, SYLVANT® should not be kept for more than 2 hours prior to adding the infusion bag.1

The infusion should be completed within 4 hours of the dilution of the reconstituted solution to the infusion bag.1

The patient should have a blood test before each dose of SYLVANT® for the first 12 months and every third dosing cycle thereafter.1 Consider delaying treatment if the following criteria are not met (dose reduction is not recommended).


Dosing

Delay treatment if the patient has a severe infection or any severe non-haematological toxicity – SYLVANT® can be restarted at the same dose after recovery.

Discontinue further SYLVANT® treatment if the patient develops:1

  • Severe infusion related reaction
  • Anaphylaxis
  • Severe allergic reaction
  • Cytokine release syndrome related to the infusion

Consider discontinuing SYLVANT® if there are more than 2 dose delays due to toxicities related to the treatment during the first 48 weeks.

Special populations – please refer to the full SmPC1 for further details.

References
1. SYLVANT® Summary of Product Characteristics (2019)